Home/Filings/4/0001415889-22-011604
4//SEC Filing

Harrington-Smith Kristen 4

Accession 0001415889-22-011604

CIK 0000855654other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 5:31 PM ET

Size

7.2 KB

Accession

0001415889-22-011604

Insider Transaction Report

Form 4
Period: 2022-11-15
Harrington-Smith Kristen
SVP & Chief Commercial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2022-11-15+25,00025,000 total
  • Exercise/Conversion

    Restricted Stock Unit

    2022-11-1525,00050,000 total
    Exercise: $0.00From: 2022-11-15Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
  • [F2]The RSUs vest over a three-year period, with one-third of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1
  • filerCIK 0001894310

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 5:31 PM ET
Size
7.2 KB